SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 654.74-0.5%Nov 10 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: CuttingEdge Bio who wrote (2982)6/4/2020 10:35:14 AM
From: Miljenko Zuanic  Read Replies (1) of 3557
 
Ego is not *takeaway*, ....is solely IOs (even as effective combinations) true answer for any cancer? is there no room for target therapies, where Roche dominate, and Regeneron missing big time?
IF REGN want to be big player in oncology need TKI (TT), IMO.

And about *ego*, you do not LAUGH on ANY analyst question, regardless how STUPID (or unrealistic) it may sound???? That is clear sign of IGNORANCE!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News